Korsana Biosciences KRSA
NASDAQ KRSA
$30.49 -0.71 (-2.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Total Debt (2020 - 2021)

Updated

Korsana Biosciences' Total Debt came in at $3.51 million for Q3 2021, unchanged from $3.51 million a year earlier and unchanged from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Total Debt (2020 - 2021) Analysis & Trends

Going back to Q2 2020, Korsana Biosciences' Total Debt data covers 6 quarters.

  • Business Quant data shows KRSA's Total Debt at $3.51 million (Q2 2021), $3.51 million (Q1 2021) and $3.51 million (Q4 2020) in the three quarters before Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 49.04 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 70.82 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 37.49 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -111.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 26.25 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 63.19 Bn
10 Korsana Biosciences 16.10 Mn 1.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 3.51 Mn
Jun 30, 2021 3.51 Mn
Mar 31, 2021 3.51 Mn
Dec 31, 2020 3.51 Mn
Sep 30, 2020 3.51 Mn
Jun 30, 2020 3.51 Mn
API Access

Korsana Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=KRSA&period=max&api_key=YOUR_API_KEY